1.0200
-0.0300
(-2.86%)
At close: April 17 at 10:00:07 PM GMT+2
Breakdown
TTM
4/30/2024
4/30/2023
Operating Expense
265.6250
265.6250
0.2340
Operating Income
-265.6250
-265.6250
-0.2340
Other Income Expense
-155.0290
-155.0290
--
Pretax Income
-420.6540
-420.6540
-0.2340
Net Income Common Stockholders
-420.6540
-420.6540
-0.2340
Diluted NI Available to Com Stockholders
-420.6540
-420.6540
-0.2340
Basic EPS
-0.01
-0.01
-0.00
Diluted EPS
-0.01
-0.01
-0.00
Basic Average Shares
38,475
38,475
38,475
Diluted Average Shares
38,475
38,475
38,475
Total Expenses
265.6250
265.6250
0.2340
Net Income from Continuing & Discontinued Operation
-420.6540
-420.6540
-0.2340
Normalized Income
-307.4828
-307.4828
-0.2340
EBIT
-265.6250
-265.6250
-0.2340
EBITDA
-265.6250
-265.6250
-0.2340
Net Income from Continuing Operation Net Minority Interest
-420.6540
-420.6540
-0.2340
Total Unusual Items Excluding Goodwill
-155.0290
-155.0290
--
Total Unusual Items
-155.0290
-155.0290
--
Normalized EBITDA
-110.5960
-110.5960
-0.2340
Tax Rate for Calcs
0.0003
0.0003
--
Tax Effect of Unusual Items
-41.8578
-41.8578
--
4/30/2023 - 12/11/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MVR0.BE Medivir AB
0.1372
-2.42%
HQ1.MU Oruka Therapeutics Inc. R
7.50
+2.04%
05Y.MU Vivoryon Therapeutics NV
1.7140
0.00%
BT3.BE Lineage Cell Therapeutics Inc
0.3600
-1.10%
PROT Proteonomix, Inc.
0.0000
0.00%
0M4.BE Mersana Therapeutics Inc
0.3110
+5.85%
ICY.HA Incyte Corp
51.16
-0.31%
HTD.MU Corcept Therapeutics Inc
57.90
-3.60%
DBV.F DBV Technologies S.A.
1.2520
+1.79%
4FR.BE Faron Pharmaceuticals Oy
2.4400
+6.09%